Načítá se...
Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
BACKGROUND: Many receptors function by binding to multiple ligands, each eliciting a distinct biological output. The extracellular domain of the human prolactin receptor (hPRL-R) uses an identical epitope to bind to both prolactin (hPRL) and growth hormone (hGH), yet little is known about how each h...
Uloženo v:
| Vydáno v: | Cell Commun Signal |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4300558/ https://ncbi.nlm.nih.gov/pubmed/25589173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-014-0080-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|